Author:
Pacurariu Alexandra C.,Straus Sabine M.,Trifirò Gianluca,Schuemie Martijn J.,Gini Rosa,Herings Ron,Mazzaglia Giampiero,Picelli Gino,Scotti Lorenza,Pedersen Lars,Arlett Peter,van der Lei Johan,Sturkenboom Miriam C.,Coloma Preciosa M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference39 articles.
1. CIOMS Working Group. Practical aspects of signal detection in pharmacovigilance: report of CIOMS Working Group VIII. Geneva: Council for International Organizations of Medical Sciences; 2010.
2. Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJW, Yuen N. Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther. 2007;82:157–66.
3. Hauben M, Bate A. Decision support methods for the detection of adverse events in post-marketing data. Drug Discov Today. 2009;14:343–57.
4. Hammad TA, Neyarapally GA, Iyasu S, Staffa JA, Dal Pan G. The future of population-based postmarket drug risk assessment: a regulator’s perspective. Clin Pharmacol Ther. 2013;94:349–58.
5. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58:323–37.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献